Acadia Pharmaceuticals Stock Price

0.92 (1.74%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.92 1.74% 53.75 15:42:01
Open Price Low Price High Price Close Price Prev Close
53.20 52.70 54.5792 52.83
Bid Price Ask Price Spread News
53.74 53.80 0.06 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,953 603,048 $ 53.69 $ 32,379,281 871,827 30.02 - 58.72
Last Trade Time Type Quantity Stock Price Currency
15:42:00 2 $ 53.77 USD

Acadia Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.55B 158.98M 91.21M $ 339.08M $ -227.11M -1.60 -30.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week54.4954.579251.4352.92673,281-0.74-1.36%
1 Month55.5655.8551.0453.46771,997-1.81-3.26%
3 Months46.5057.4644.7853.03935,4127.2515.59%
6 Months43.6757.4636.3245.721,065,91710.0823.08%
1 Year38.8058.7230.0245.661,266,49014.9538.53%
3 Years31.0058.7212.7729.331,825,83322.7573.39%
5 Years24.1158.7212.7729.771,911,12329.64122.94%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.